Serum sodium to chloride ratio and mortality on continuous ambulatory peritoneal dialysis: a multicenter retrospective study

Abstract

An imbalance in the serum sodium to chloride ratio (Na/Cl) was linked to higher mortality among heart failure patients. Nonetheless, the prognostic significance of Na/Cl in individuals undergoing peritoneal dialysis (PD) remains unexplored. This study seeks to explore the association between initial Na/Cl levels and mortality in PD patients. The study, conducted across multiple centers, included 3341 patients undergoing PD from January 1, 2005, to December 31, 2021. Patients were stratified into quartiles according to baseline Na/Cl and followed up for a median of 5.77 years. To explore the association between Na/Cl levels and mortality, we employed Cox proportional hazards models, competing risks models, and restricted cubic spline analysis. Of 3341 patients, 722 patients died, including 259 cardiovascular deaths. Following adjustments for comorbidities and multiple covariates, individuals in the highest Na/Cl quartile (>1.42) exhibited lower all-cause mortality (hazard ratio [HR] 0.63, 95% confidence interval [CI] 0.47–0.86) and cardiovascular mortality (HR 0.38, 95% CI 0.22–0.67) compared with those in the lowest quartile (<1.33). A similar pattern was also found when Na/Cl was dealt with continuous variables. Initial levels of Na/Cl at the start of PD were negatively correlated with all-cause mortality and cardiovascular mortality in PD patients.

Keywords

all-cause mortality / cardiovascular mortality / peritoneal dialysis / sodium-to-chloride ratio

References

[1] Thurlow JS, Joshi M, Yan G, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021; 52(2): 98-107.

[2] Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385(9981): 1975-1982.

[3] Dhondup T, Qian Q. Acid-base and electrolyte disorders in patients with and without chronic kidney disease: an update. Kidney Dis (Basel). 2017; 3(4): 136-148.

[4] Kovesdy CP, Lott EH, Lu JL, et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012; 125(5): 677-684.

[5] Sasakawa Y, Tatematsu Y, Kato J, Fujii M, Okamoto N, Inaguma D. Relationship between serum sodium level at dialysis initiation and all-cause mortality. Clin Exp Nephrol. 2023; 27(9): 747-756.

[6] Marroquin MV, Sy J, Kleine CE, et al. Association of pre-ESKD hyponatremia with post-ESKD outcomes among incident ESKD patients. Nephrol Dial Transplant. 2022; 37(2): 358-365.

[7] Nigwekar SU, Wenger J, Thadhani R, Hyponatremia BhanI, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study. Am J Kidney Dis. 2013; 62(4): 755-762.

[8] Han SW, Tilea A, Gillespie BW, et al. Serum sodium levels and patient outcomes in an ambulatory clinic-based chronic kidney disease cohort. Am J Nephrol. 2015; 41(3): 200-209.

[9] Waikar SS, Curhan GC, Brunelli SM. Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med. 2011; 124(1): 77-84.

[10] Hecking M, Karaboyas A, Saran R, et al. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2012; 59(2): 238-248.

[11] Chang TI, Kim YL, Kim H, et al. Hyponatremia as a predictor of mortality in peritoneal dialysis patients. PloS one. 2014; 9(10): e111373.

[12] Ravel VA, Streja E, Mehrotra R, et al. Serum sodium and mortality in a national peritoneal dialysis cohort. Nephrol Dial Transplant. 2017; 32(7): 1224-1233.

[13] Dimitriadis C, Sekercioglu N, Pipili C, Oreopoulos D, Bargman JM, Hyponatremia in peritoneal dialysis: epidemiology in a single center and correlation with clinical and biochemical parameters. Perit Dial Int. 2014; 34(3): 260-270.

[14] Zhou L, Wang X, Zhan X, et al. Serum chloride and mortality in patients on continuous ambulatory peritoneal dialysis: a multi-center retrospective study. EClinicalMedicine. 2021; 41: 101133.

[15] Li H, Wang Y, Xu Y, et al. Association between serum chloride levels with mortality in incident peritoneal dialysis patients. Nutr Metab Cardiovasc Dis. 2022; 32(3): 624-631.

[16] Grodin JL, Simon J, Hachamovitch R, et al. Prognostic role of serum chloride levels in acute decompensated heart failure. J Am Coll Cardiol. 2015; 66(6): 659-666.

[17] Grodin JL, Verbrugge FH, Ellis SG, Mullens W, Testani JM, Tang WH. Importance of abnormal chloride homeostasis in stable chronic heart failure. Circ Heart Fail. 2016; 9(1): e002453.

[18] Testani JM, Hanberg JS, Arroyo JP, et al. Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure. Eur J Heart Fail. 2016; 18(6): 660-668.

[19] Cuthbert JJ, Pellicori P, Rigby A, et al. Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. Eur J Heart Fail. 2018; 20(10): 1426-1435.

[20] Hanberg JS, Rao V, Ter Maaten JM, et al. Hypochloremia and diuretic resistance in heart failure: mechanistic insights. Circ Heart Fail. 2016; 9(8): e003180.

[21] Fu Z, Zhang X, Zhao X, Wang Q. U-shaped relationship of sodium-to-chloride ratio on admission and mortality in elderly patients with heart failure: a retrospective cohort study. Curr Probl Cardiol. 2023; 48(1): 101419.

[22] Zhang Y, Peng R, Li X, Yu J, Chen X, Zhou Z. Serum chloride as a novel marker for adding prognostic information of mortality in chronic heart failure. Clin Chim Acta. 2018; 483: 112-118.

[23] He X, Liu C, Chen Y, He J, Dong Y, Risk of cardiovascular mortality associated with serum sodium and chloride in the general population. Can J Cardiol. 2018; 34(8): 999-1003.

[24] Walsh C, Browne LD, Gilligan R, et al. Impact of serum sodium concentrations, and effect modifiers on mortality in the Irish Health System. BMC Nephrol. 2023; 24(1): 203.

[25] McCallum L, Jeemon P, Hastie CE, et al. Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension. 2013; 62(5): 836-843.

[26] Prins KW, Kalra R, Rose L, et al. Hypochloremia is a noninvasive predictor of mortality in pulmonary arterial hypertension. J Am Heart Assoc. 2020; 9(5): e015221.

[27] Pfortmueller CA, Uehlinger D. Serum chloride levels in critical illness-the hidden story. Intensive Care Med Exp. 2018; 6(1): 10.

[28] Ferreira JP, Girerd N, Duarte K, et al. Serum chloride and sodium interplay in patients with acute myocardial infarction and heart failure with reduced ejection fraction: an analysis from the high-risk myocardial infarction database initiative. Circ Heart Fail. 2017; 10(2): e003500.

[29] O’Connor CM, Ahmad T. The role of sodium and chloride in heart failure: does it take two to Tango?. J Am Coll Cardiol. 2015; 66(6): 667-669.

[30] Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004; 65(3): 1031-1040.

[31] Urso C, Brucculeri S, Caimi G. Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev. 2015; 20(4): 493-503.

[32] Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006; 48(5): e247-346.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.